Full Year 2022 Basilea Pharmaceutica AG Earnings Call Transcript
Ladies and gentlemen, welcome to the Basilea Pharmaceutica Full Year Results 2022 Conference Call and Live Webcast. I'm Alice, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to David Veitch, Chief Executive Officer. Please go ahead, sir.
Thank you. Hello, I'm David Veitch, CEO of Basilea. And I'd like to welcome you to our conference call and webcast. We'll review our financial results and key achievements for the full year 2022 and also outline the progress we've made in the implementation of our strategy to become a leading global anti-infectives company and highlight the upcoming milestones.
For further detailed information, please see the ad hoc announcement issued this morning, and also our full year report 2022. These documents are both available on our website at basilea.com.
I'd like to mention that this call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |